A case of acute cholestatic hepatitis associated with the seeds of Psoralea corylifolia (Boh-Gol-Zhee)

Clinical Toxicology

Volumn 43, Issue 6, 2005, Pages 589-591

  Nam, Soon Woo ^a   Baek, Jong Tae ^a   Lee, Dong Soo ^a   Kang, Sang Bum ^a   Ahn, Byung Min ^a,b   Chung, Kyu Won ^a  

^a The Catholic University of Korea   (South Korea)

^b St Mary's Hospital   (South Korea)

Author keywords

Acute cholestatic hepatitis; Psoralea corylifolia

Indexed keywords

NATURAL PRODUCT;

ADULT; ALTERNATIVE MEDICINE; ARTICLE; BOH GOL ZHEE; CASE REPORT; CELL INFILTRATION; CHOLESTASIS; CHOLESTATIC HEPATITIS; FEMALE; HUMAN; HUMAN TISSUE; INFLAMMATORY CELL; LIVER BIOPSY; LIVER NECROSIS; LIVER TOXICITY; OSTEOPOROSIS; PLANT INTOXICATION; PLANT SEED; POSTMENOPAUSE; PSORALEA; PSORALEA CORYLIFOLIA;

ACUTE DISEASE; ADULT; CHOLESTASIS; FEMALE; HEPATITIS, TOXIC; HUMANS; MEDICINE, HERBAL; PLANT POISONING; PSORALEA; SEEDS;

CULLEN CORYLIFOLIA; PSORALEA;

EID: 26844490977     PISSN: 07313810     EISSN: 10979875     Source Type: Journal    
DOI: 10.1081/CLT-200068863     Document Type: Article

References (16)

1. Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, Delbanko TL. Unconventional medicine in the United States. Prevalence, costs and patterns of use. N Engl J Med 1993; 328:246-252.
2. Kaplowitz N. Hepatotoxicity of herbal remedies: insights into the intricacies of plant-animal warfare and cell death. Gastroenterology 1997; 113(4):1408-1411.
3. Association of Professors in the Korean Medical Universities of Oriental Medicine. Oriental Medicine. Seoul: Bonchohak Yeongrimsa Press, 1991:559.
4. Yao S, Yang B, Xu Z. Determination of bakuchiol in the fruit of Psoralea corylifolia L. Chung Kuo Chung Yao Tsa Chih 1995; 20:681-683.
5. Yang YM, Hyun JW, Sung MS. The cytotoxicity of psoralidin from Psoralea corylifolia. Planta Med 1996; 62:353-354.
6. Tsai WJ, Hsin WC, Chen CC. Antiplatelet flavonoids from seeds of Psoralea corylifolia. J Nat Prod 1996; 59:671-672.
7. Ji L, Xu Z. Review of constituents in fruits of Psoralea corylifolia L. Chung Kuo Chung Yao Tsa Chih 1995; 20:120-128.
8. Kaufman PB, Duke JA, Brielmann H, Boik J, Hoyt JE. A comparative survey of leguminous plants as sources of the isoflavones, genistein and daidzein: implications for human nutrition and health. J Altern Complement Med 1997; 3:7-12.
9. Ishimi Y, Arai N, Wang X, Wu J, Umegaki K, Miyaura C, Takeda A, Ikegami S. Difference in effective dosage of genistein on bone and uterus in ovariectomized mice. Biochem Biophys Res Commun 2000; 274:697-701.
10. Maria VA, Victorino RM. Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis. Hepatology 1997; 26:664-669.
11. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30(2):239-245.
12. Shakil A, Kramer D, Mazariegos G, Fung JJ, Rakela J. Acute liver failure: clinical features, outcome analysis, and applicability of prognostic criteria. Liver Transplant 2000; 16:163-169.
13. Zimmerman H. Drug-induced liver disease. In: Schiff E, Sorrell M, Maddrey W, eds. Schiff's Disease of the Liver. 8th ed. Philadelphia: Lippincott-Raven Publishers, 1999:973-1064.
14. Kaplowitz N. Drug metabolism and hepatotoxicity. In: Kaplowitz N, ed. Liver and Biliary Diseases. 2nd ed. Baltimore: Williams and Wilkins, 1996:103-120.
15. Kaplowitz N. Drug-induced liver disorders. Drug Safety 2001; 24(7):483-490.
16. Beaune P, Pessayre D, Dansette PM, Mansuy D, Manns M. Autoantibodies against cytochrome P450: role in human disease. Adv Pharmacol 1994; 30:199-245.